uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
about
Fluorescent imaging of cancerous tissues for targeted surgery.Targeted nanotechnology for cancer imaging.Prostate cancer relevant antigens and enzymes for targeted drug deliveryAdvances in fluorescent-image guided surgeryIncreased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probesIntraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical MarginsThe targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapyIntraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology.Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer.Peptide-Based Optical uPAR Imaging for Surgery: In Vivo Testing of ICG-Glu-Glu-AE105uPAR-targeted multimodal tracer for pre- and intraoperative imaging in cancer surgeryDual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo.Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advancesPreclinical evaluation of a urokinase plasminogen activator receptor-targeted nanoprobe in rhesus monkeysIGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic CancerGreen Tea Catechin-Based Complex Micelles Combined with Doxorubicin to Overcome Cardiotoxicity and Multidrug Resistance.Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.Selecting Tumor-Specific Molecular Targets in Pancreatic Adenocarcinoma: Paving the Way for Image-Guided Pancreatic Surgery.Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging.uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.Diverse Applications of Nanomedicine.Nanotechnology applications in diagnosis and treatment of metastasis.Current status of biomarker and targeted nanoparticle development: The precision oncology approach for pancreatic cancer therapy.Prognostic Impact of Urokinase Plasminogen Activator Receptor Expression in Pancreatic Cancer: Malignant Versus Stromal Cells.Doxorubicin-loaded redox-responsive micelles based on dextran and indomethacin for resistant breast cancer.A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells.Targeted Delivery of siRNA Therapeutics to Malignant Tumors.Tumor targeted mesoporous silica-coated gold nanorods facilitate detection of pancreatic tumors using Multispectral optoacoustic tomography
P2860
Q26830905-3C244DBD-C4FC-4A82-B2B6-EADF37C928ABQ27010317-DA6816E6-0F04-41F3-8B11-BF8ACDEB18C2Q27013843-FAA8E3B8-6E23-4164-AF72-E3193289AFBEQ28072620-63811CAD-4311-4F58-8E1B-71D2327FE7F9Q30665907-BCDCCA42-BDA1-494C-8E20-691D15999ECAQ33808756-F330AA2B-9C84-44F5-B82B-0D1DE30EC1B1Q33976984-375807BA-C4CE-4910-9479-693AECAB0880Q34195631-DE4F32BF-100D-4131-9656-906913FF9346Q34698633-3BC09BA1-2234-4622-A582-D8AA5417AB13Q35227499-828CBB32-66F0-430F-83F1-9373717DF171Q35909379-BC805368-ACB1-4A2B-AC09-77D68A88F482Q35987322-DF9C05EC-EDB7-48B4-8A31-FD7D6D8EA44AQ36010344-5375E850-4A36-4FDA-BADD-2CDC8DDE16B3Q36157045-742C160B-2D23-4108-A705-72E25C6C2304Q36240694-7C2F563E-39C1-4C65-A6DB-F27F00A2B762Q37007341-40B4BB9C-D559-45AD-9EEB-965C7DA6403FQ37045928-449F0C9C-C16A-4CE0-9E6A-3F690232F7DCQ37082778-E694144F-DF7C-4047-8572-4FA138FEB4F1Q37389699-0869F10B-A6D6-4B5E-A318-AEF244C5C649Q37541860-F256B181-682A-4D1A-AB95-F3A98F87E44DQ37716562-02523C84-8B46-42B7-9F80-D7F98CA28CBFQ37728142-F40B0B02-6209-49AF-8E94-73C961DF9DF5Q38254086-B9B1D2D6-E630-455B-9680-E7593B71C1AAQ39028976-2522B9E2-BC34-4F0B-B9C1-79D8783501DDQ39424309-921F93B4-FC05-4C06-AD28-23C45929C904Q41545913-631CF362-B03A-4E61-8608-D3B5B19A2890Q42510684-59E35994-F3EC-4BB8-BFB8-2354D1703849Q47152520-96F519BE-E9F5-40ED-95EC-75937BA16331Q57353110-5B190716-6FA4-4215-9DD0-8DAE6B797E5E
P2860
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@en
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@nl
type
label
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@en
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@nl
prefLabel
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@en
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@nl
P2093
P2860
P356
P1433
P1476
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection.
@en
P2093
Adam I Marcus
Hari Krishna Sajja
Laura Bender
Malgorzata Lipowska
Weiping Qian
William C Wood
Y Andrew Wang
Zehong Cao
P2860
P304
P356
10.7150/THNO.7409
P577
2013-12-17T00:00:00Z